Your browser doesn't support javascript.
loading
Purity Determination of Cyclophosphamide Hydrate by Quantitative 31P-NMR and Method Validation.
Uchiyama, Nahoko; Hosoe, Junko; Sugimoto, Naoki; Ishizuki, Kyoko; Koide, Tatsuo; Murabayashi, Mika; Miyashita, Naoto; Kobayashi, Kengo; Fujimine, Yoshinori; Yokose, Toshiyuki; Ofuji, Katsuya; Shimizu, Hitoshi; Hasebe, Takashi; Asai, Yumi; Ena, Eri; Kikuchi, Junko; Kiyota, Kohei; Fujita, Kazuhiro; Makino, Yoshinobu; Yasobu, Naoko; Iwamoto, Yoshiaki; Miura, Toru; Mizui, Koji; Asakura, Katsuo; Suematsu, Takako; Muto, Hitomi; Kohama, Ai; Goto, Takashi; Yasuda, Masu; Ueda, Tomohiko; Goda, Yukihiro.
Afiliação
  • Uchiyama N; National Institute of Health Sciences (NIHS).
  • Hosoe J; National Institute of Health Sciences (NIHS).
  • Sugimoto N; National Institute of Health Sciences (NIHS).
  • Ishizuki K; National Institute of Health Sciences (NIHS).
  • Koide T; National Institute of Health Sciences (NIHS).
  • Murabayashi M; Takeda Pharmaceutical Co., Ltd.
  • Miyashita N; Daiichi Sankyo Co., Ltd.
  • Kobayashi K; Daiichi Sankyo Co., Ltd.
  • Fujimine Y; Otsuka Pharmaceutical Co., Ltd.
  • Yokose T; Otsuka Pharmaceutical Co., Ltd.
  • Ofuji K; Chugai Pharma Manufacturing Co., Ltd.
  • Shimizu H; Chugai Pharma Manufacturing Co., Ltd.
  • Hasebe T; Eisai Co., Ltd.
  • Asai Y; Eisai Co., Ltd.
  • Ena E; Eisai Co., Ltd.
  • Kikuchi J; SHIONOGI & Co., Ltd.
  • Kiyota K; SHIONOGI & Co., Ltd.
  • Fujita K; SHIONOGI & Co., Ltd.
  • Makino Y; Juzen Chemical Corp.
  • Yasobu N; FUJIFILM Corporation.
  • Iwamoto Y; FUJIFILM Wako Pure Chemical Corporation.
  • Miura T; FUJIFILM Wako Pure Chemical Corporation.
  • Mizui K; FUJIFILM Wako Pure Chemical Corporation.
  • Asakura K; JEOL Ltd.
  • Suematsu T; JEOL RESONANCE Inc.
  • Muto H; JEOL RESONANCE Inc.
  • Kohama A; Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ).
  • Goto T; Nippon Shinyaku Co., Ltd.
  • Yasuda M; Nippon Shinyaku Co., Ltd.
  • Ueda T; Sumitomo Dainippon Pharma Co., Ltd.
  • Goda Y; National Institute of Health Sciences (NIHS).
Chem Pharm Bull (Tokyo) ; 69(7): 630-638, 2021 Jul 01.
Article em En | MEDLINE | ID: mdl-33853973
ABSTRACT
Recently, quantitative NMR (qNMR), especially 1H-qNMR, has been widely used to determine the absolute quantitative value of organic molecules. We previously reported an optimal and reproducible sample preparation method for 1H-qNMR. In the present study, we focused on a 31P-qNMR absolute determination method. An organophosphorus compound, cyclophosphamide hydrate (CP), listed in the Japanese Pharmacopeia 17th edition was selected as the target compound, and the 31P-qNMR and 1H-qNMR results were compared under three conditions with potassium dihydrogen phosphate (KH2PO4) or O-phosphorylethanolamine (PEA) as the reference standard for 31P-qNMR and sodium 4,4-dimethyl-4-silapentanesulfonate-d6 (DSS-d6) as the standard for 1H-qNMR. Condition 1 separate sample containing CP and KH2PO4 for 31P-qNMR or CP and DSS-d6 for 1H-qNMR. Condition 2 mixed sample containing CP, DSS-d6, and KH2PO4. Condition 3 mixed sample containing CP, DSS-d6, and PEA. As conditions 1 and 3 provided good results, validation studies at multiple laboratories were further conducted. The purities of CP determined under condition 1 by 1H-qNMR at 11 laboratories and 31P-qNMR at 10 laboratories were 99.76 ± 0.43 and 99.75 ± 0.53%, respectively, and those determined under condition 3 at five laboratories were 99.66 ± 0.08 and 99.61 ± 0.53%, respectively. These data suggested that the CP purities determined by 31P-qNMR are in good agreement with those determined by the established 1H-qNMR method. Since the 31P-qNMR signals are less complicated than the 1H-qNMR signals, 31P-qNMR would be useful for the absolute quantification of compounds that do not have a simple and separate 1H-qNMR signal, such as a singlet or doublet, although further investigation with other compounds is needed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Água / Ciclofosfamida Idioma: En Revista: Chem Pharm Bull (Tokyo) Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Água / Ciclofosfamida Idioma: En Revista: Chem Pharm Bull (Tokyo) Ano de publicação: 2021 Tipo de documento: Article